Featured News

On August 29, 2019, the Celiac Disease Foundation’s 7th Annual New York Golf Outing was held at the New York Country Club in New Hempstead, NY.

CEO Marilyn G. Geller speaks at the 18th International Celiac Disease Symposium (ICDS).

ActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.

Julie McCormack discusses her annual AITI Golf Outing and why she continues to be a Celiac Disease Foundation top Team Gluten-Free fundraiser.

Often, when a patient is following a long-term gluten-free diet with good compliance, micronutrient deficiencies cannot be detected. This review - published in the scientific journal Medicina - evaluates the most recent literature on micronutrient deficiencies in patients following a long-term gluten-free diet in order to provide dietary supplementation advice. The study concludes that in patients with micronutrient deficiencies caused by celiac disease, vitamin supplements may be necessary.

The Celiac Disease Foundation is proud to announce that Bradley J. Herrema, Secretary of the Foundation’s Board of Directors, has been selected for recognition as one the 2020 Best Lawyers in America.

The Celiac Disease Foundation was proud to be an endorsement partner of the 2019 James W. Freston Conference – Food at the Intersection of Gut Health and Disease to educate…

On August 13th, 2019, Innovate Biopharmaceuticals, Inc. (Innovate) announced the first patient has been dosed in its Phase 3 clinical trial for patients with celiac disease. The CeD LA 3001…

Team Gluten-Free runners will run the 26.2 miles in the 2019 TCS NYC Marathon to accelerate research for the three million Americans affected by celiac disease.

As a member of the National Coalition of Autoimmune Patients Groups (NCAPG), a coalition founded by the American Autoimmune Related Diseases Association (AARDA), the Celiac Disease Foundation signed onto the proposed…